Zillion, a leading health technology company, today announced that Linda McGoldrick has been appointed its new President and Chief Executive Officer, effective immediately.
In her 30-year career of working predominantly at the CEO level and in both senior executive and advisory roles, McGoldrick has guided multinational companies in developing new technology and expanding across existing geographic markets, while providing deep expertise in navigating complex financial and healthcare regulatory environments.
McGoldrick currently serves on several corporate boards, including Delta Dental of Rhode Island and Avadim Health, and previously served on the boards of numerous listed companies (NYSE, NASDAQ, London, Oslo, AIM Exchanges) as well as private corporations. Additionally, she has held four Ministerial appointments in the UK and was appointed by the Governor of Rhode Island to the Health Reform Commission and by the Governor of Massachusetts to the Health Information Technology Commission. McGoldrick is also the founder and chairperson of Financial Health Associates International (FHAI), a global strategy and board advisory firm.
“We’re eager to push Zillion into the next phase of development and Linda is a perfect fit to lead our efforts,” said Demos Kouvaris, Zillion board member. “Her deep experience developing strategy and producing value creation for key players in the healthcare industry, as well as her leadership across global business and product development, marketing and new venture promotion, and both private and public partnerships brings tremendous value to Zillion as we continue to expand and drive our growth strategy.”
“The future of healthcare is patient empowerment and individualized programs for preventative action – two areas where Zillion is leading the charge,” said McGoldrick. “I look forward to working with the seasoned team currently in place at Zillion to capitalize on the positive, thought-leading momentum already built and further improve patient experience and health outcomes by building the architecture for incremental behavioral change and lasting impact.”
To learn more about Zillion or to speak with a Zillion representative about how the Restore Program, the platform, or any of its clinical programs can address condition management across an employer population, please visit us at www.zillion.com or call 855.475.5123.
Zillion is a leading behavior modification company offering solutions that blend technology, people, and content to deliver impactful programs that target the most pervasive chronic health conditions globally. Our delivery model is focused on supporting individual choice and preference, to nudge users towards long-lasting healthy habits and real behavior change. Since its commercial launch in 2015, Zillion has collected over 100 million data points from over 750,000 users to power the identification of choice patterns that influence and manage high-risk factors for better outcomes, higher quality of care and lower costs. Zillion’s products provide a powerful consumer experience fueled by technology and integrated by human care teams and include programs such as Restore to address the full spectrum of care issues like chronic and non-communicable diseases. www.Zillion.com